Detalles de la búsqueda
1.
[A Case of Lung Adenocarcinoma Presenting with Leptomeningeal Carcinomatosis Successfully Treated with Afatinib after Erlotinib-Induced Hepatotoxicity].
Gan To Kagaku Ryoho;
44(7): 595-597, 2017 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-28790264
2.
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence].
Gan To Kagaku Ryoho;
44(9): 767-770, 2017 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-28912406
3.
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.
Support Care Cancer;
23(7): 2129-33, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25547482
4.
Association of serum adiponectin with asthma and pulmonary function in the Japanese population.
Endocr J;
62(8): 695-709, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985757
5.
[Efficacy and toxicity of pemetrexed monotherapy for previously untreated elderly patients with non-squamous cell lung cancer with wild-type(or unknown)EGFR status].
Gan To Kagaku Ryoho;
41(7): 849-52, 2014 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-25131870
6.
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
In Vivo;
38(3): 1509-1511, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688637
7.
Comparison of the efficacy of first/secondgeneration EGFRtyrosine kinase inhibitors and osimertinib for EGFRmutant lung cancer with negative or low PDL1 expression.
Mol Clin Oncol;
20(6): 43, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756869
8.
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Anticancer Res;
44(3): 1241-1245, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423671
9.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Target Oncol;
19(3): 423-433, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613731
10.
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
Respirology;
18(2): 332-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23062010
11.
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumorinfiltrating CD68positive cell counts in patients with EGFRmutant nonsmall cell lung cancer.
Mol Clin Oncol;
18(5): 38, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37035471
12.
A retrospective study of the efficacy of combined EGFRTKI plus VEGF inhibitor/cytotoxic therapy vs. EGFRTKI monotherapy for PDL1positive EGFRmutant nonsmall cell lung cancer: North Japan Lung Cancer Study Group 2202.
Oncol Lett;
26(2): 334, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427337
13.
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Sci Rep;
13(1): 10807, 2023 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402763
14.
Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors.
Anticancer Res;
43(7): 3241-3246, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37351972
15.
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
Thorac Cancer;
14(17): 1618-1623, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101081
16.
Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Respir Investig;
60(2): 197-204, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34896039
17.
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Cancer Diagn Progn;
2(3): 324-329, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35530643
18.
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Lung Cancer;
172: 1-8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952438
19.
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
JTO Clin Res Rep;
3(11): 100404, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275911
20.
[Synchronous pulmonary hamartoma and lung cancer in a young patient].
Nihon Kokyuki Gakkai Zasshi;
49(5): 349-54, 2011 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-21688642